Royalty Rate. Licensee shall pay to Licensor three percent (3%) of the first $25 million of Revenues received by Licensee or its Affiliates, and two percent (2%) of all additional Revenues received by Licensee or its Affiliates, subject to reductions pursuant to Sections 4.2.2 and 4.2.3.
Appears in 5 contracts
Samples: License Agreement (VistaGen Therapeutics, Inc.), License Agreement (VistaGen Therapeutics, Inc.), License Agreement Number (VistaGen Therapeutics, Inc.)
Royalty Rate. Licensee shall pay to Licensor three percent (3%) of the first $US$25 million of cumulative Revenues received by Licensee or its Affiliates, and two percent (2%) of all additional cumulative Revenues received by Licensee or its Affiliates, subject to reductions pursuant to Sections 4.2.2 4.2.4 and 4.2.34.2.5.
Appears in 2 contracts
Samples: License Agreement (VistaGen Therapeutics, Inc.), License Agreement (VistaGen Therapeutics, Inc.)
Royalty Rate. Licensee shall pay to Licensor three percent (3%) of the first $25 million of cumulative Revenues received by Licensee or its Its Affiliates, and two percent (2%) of all additional cumulative Revenues received by Licensee licensee or its Affiliates, subject to reductions pursuant to Sections 4.2.2 4.2.4 and 4.2.3.4.2.S.
Appears in 2 contracts
Samples: License Agreement (VistaGen Therapeutics, Inc.), License Agreement (VistaGen Therapeutics, Inc.)
Royalty Rate. Licensee shall pay to Licensor three percent (3%) of the first $25 million of Revenues received by Licensee or its Affiliates, and two percent (2%) of all additional Revenues received by Licensee or its Affiliates, subject to reductions pursuant to Sections 4.2.2 and 4.2.3.. 4.2.2
Appears in 1 contract
Samples: License Agreement
